MD Anderson Cancer Center receives $8 million in CPRIT funding for screening and early detection programs, faculty recruitment
The University of Texas MD Anderson Cancer Center was awarded nearly $8 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of faculty recruitment as well as lung and colorectal cancer screening and early detection programs to address cancer incidence rates across Texas.
“CPRIT’s continued support is essential for progress in our mission to end cancer, and we appreciate this important funding.
Our unique research ecosystem enables breakthroughs across all disciplines, and these new screening and early detection programs will contribute significantly to addressing the cancer burden for medically underserved Texans,” – said Peter WT Pisters, President of MD Anderson.
The Project 80% colorectal cancer screening program, led by Lewis Foxhall, Professor of Clinical Cancer Prevention, was awarded $2,499,990. This multi-component screening and diagnostics program serves 64 counties across Texas, partnering with federally qualified health centers and other community clinics to help with early detection and prevention of colorectal cancer.
Jennifer Minnix, Assistant Professor of Behavioral Science, was awarded $1,497,342 in support of the Virtual, Centralized Lung Cancer Screening Program for Northeast Texas, which aims to provide lung cancer screening and diagnostic services with shared decision making and tobacco cessation services for high-risk areas in Northeast Texas.
In addition to these program awards, CPRIT also awarded $4 million for the recruitment of two first-time, tenure-track faculty.
Since its inception, CPRIT has awarded over $3.7 billion in grants for cancer research. MD Anderson investigators have received over $657 million all told, approximately 18% of the total awards. Programs supported by CPRIT funding have brought more than 324 distinguished cancer researchers to Texas, advanced the knowledge base for cancer treatment throughout the state and provided more than 10.1 million cancer prevention and early detection services reaching all 254 counties in Texas.
About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world’s most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation’s first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings and has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).
Other posts featuring MD Anderson Cancer Center:
MD Anderson Research Highlights: SITC 2024 Special Edition
MD Anderson Cancer Center’s Lymphoma-Myeloma Fellowship Program
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023